Cardio-Oncology and Heart Failure: AL Amyloidosis for the Heart Failure Clinician: a Supplement to the Scientific Statement from the Heart Failure Society of America

BLOOM, M. W., VO, J. B., RODGERS, J. E., FERRARI, A. M., NOHRIA, A., DESWAL, A., CHENG, R. K., KITTLESON, M. M., UPSHAW, J. N., PALASKAS, N., BLAES, A., BROWN, S.-A., KY, B., LENIHAN, D., MAURER, M. S., FADOL, A., SKURKA, K., CAMBARERI, C., & BARAC, A. (2024). Cardio-Oncology and Heart Failure: AL Amyloidosis for the Heart Failure Clinician: a Supplement to the Scientific Statement from the Heart Failure Society of America. Journal of Cardiac Failure. https://doi.org/10.1016/j.cardfail.2024.08.046
Authors:
Michelle Weisfelner Bloom
Jacqueline B Vo
Jo E Rodgers
Alana M Ferrari
Anju Nohria
Anita Deswal
Richard K Cheng
Michelle M Kittleson
Jenica N Upshaw
Nicolas Palaskas
Anne Blaes
Sherry-Ann Brown
Bonnie Ky
Daniel Lenihan
Mathew S Maurer
Anecita Fadol
Kerry Skurka
Christine Cambareri
Ana Barac
Affiliated Authors:
Mathew S Maurer
Author Keywords:
heart failure
cancer
cardiotoxicity
cardio-oncology
cancer treatment-related cardiac dysfunction
cardio-myopathy
heart failure with reduced ejection fraction
heart failure with preserved ejection fraction
bone marrow/stem cell transplant
pulmonary
cardiomyopathy
Publication Type:
Article
Unique ID:
10.1016/j.cardfail.2024.08.046
PMID:
Publication Date:
Data Source:
PubMed

Record Created: